227 related articles for article (PubMed ID: 32019321)
1. The Tasmanian Atrial Fibrillation Study (TAFS): Differences in Stroke Prevention According to Sex.
Pilcher SM; Alamneh EA; Chalmers L; Bereznicki LR
Ann Pharmacother; 2020 Sep; 54(9):837-845. PubMed ID: 32019321
[No Abstract] [Full Text] [Related]
2. The Tasmanian atrial fibrillation study: Transition to direct oral anticoagulants 2011-2015.
Alamneh EA; Chalmers L; Bereznicki LR
Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28177198
[TBL] [Abstract][Full Text] [Related]
3. Changes in Oral Anticoagulant Prescribing for Stroke Prevention in Patients With Atrial Fibrillation.
Admassie E; Chalmers L; Bereznicki LR
Am J Cardiol; 2017 Oct; 120(7):1133-1138. PubMed ID: 28781025
[TBL] [Abstract][Full Text] [Related]
4. Thromboembolic, bleeding, and mortality risks among patients with nonvalvular atrial fibrillation treated with dual antiplatelet therapy versus oral anticoagulants: A population-based study.
Lau WCY; Douglas IJ; Wong ICK; Smeeth L; Lip GYH; Leung WK; Siu CW; Cheung BMY; Mok MTC; Chan EW
Heart Rhythm; 2020 Jan; 17(1):33-40. PubMed ID: 31377423
[TBL] [Abstract][Full Text] [Related]
5. Thromboembolism and Mortality in the Tasmanian Atrial Fibrillation Study.
Admassie E; Chalmers L; Bereznicki LR
J Cardiovasc Pharmacol Ther; 2018 Jul; 23(4):329-336. PubMed ID: 29642709
[TBL] [Abstract][Full Text] [Related]
6. Exploring the Quality of Anticoagulant Prescribed for Patients With Atrial Fibrillation at the St John of God Hawkesbury District Health Centre, New South Wales, Australia.
Wertheimer G; Bereznicki LR
J Cardiovasc Pharmacol Ther; 2019 Jan; 24(1):46-53. PubMed ID: 29962220
[TBL] [Abstract][Full Text] [Related]
7. Incidence of nonvalvular atrial fibrillation and oral anticoagulant prescribing in England, 2009 to 2019: A cohort study.
Ajabnoor AM; Zghebi SS; Parisi R; Ashcroft DM; Rutter MK; Doran T; Carr MJ; Mamas MA; Kontopantelis E
PLoS Med; 2022 Jun; 19(6):e1004003. PubMed ID: 35671329
[TBL] [Abstract][Full Text] [Related]
8. Effect of Mailing Educational Material to Patients With Atrial Fibrillation and Their Clinicians on Use of Oral Anticoagulants: A Randomized Clinical Trial.
Pokorney SD; Cocoros N; Al-Khalidi HR; Haynes K; Li S; Al-Khatib SM; Corrigan-Curay J; Driscoll MR; Garcia C; Calvert SB; Harkins T; Jin R; Knecht D; Levenson M; Lin ND; Martin D; McCall D; McMahill-Walraven C; Nair V; Parlett L; Petrone A; Temple R; Zhang R; Zhou Y; Platt R; Granger CB
JAMA Netw Open; 2022 May; 5(5):e2214321. PubMed ID: 35639381
[TBL] [Abstract][Full Text] [Related]
9. Association of Race and Ethnicity With Oral Anticoagulation and Associated Outcomes in Patients With Atrial Fibrillation: Findings From the Get With The Guidelines-Atrial Fibrillation Registry.
Essien UR; Chiswell K; Kaltenbach LA; Wang TY; Fonarow GC; Thomas KL; Turakhia MP; Benjamin EJ; Rodriguez F; Fang MC; Magnani JW; Yancy CW; Piccini JP
JAMA Cardiol; 2022 Dec; 7(12):1207-1217. PubMed ID: 36287545
[TBL] [Abstract][Full Text] [Related]
10. Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.
Taillandier S; Olesen JB; Clémenty N; Lagrenade I; Babuty D; Lip GY; Fauchier L
J Cardiovasc Electrophysiol; 2012 Jul; 23(7):708-13. PubMed ID: 22268375
[TBL] [Abstract][Full Text] [Related]
11. Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS
Katz DF; Maddox TM; Turakhia M; Gehi A; O'Brien EC; Lubitz SA; Turchin A; Doros G; Lei L; Varosy P; Marzec L; Hsu JC
Circ Cardiovasc Qual Outcomes; 2017 May; 10(5):. PubMed ID: 28506981
[TBL] [Abstract][Full Text] [Related]
12. Oral Anticoagulation and the Risk of Stroke or Death in Patients With Atrial Fibrillation and One Additional Stroke Risk Factor: The Loire Valley Atrial Fibrillation Project.
Fauchier L; Lecoq C; Clementy N; Bernard A; Angoulvant D; Ivanes F; Babuty D; Lip GY
Chest; 2016 Apr; 149(4):960-8. PubMed ID: 26425935
[TBL] [Abstract][Full Text] [Related]
13. Oral anticoagulation use by patients with atrial fibrillation in Germany. Adherence to guidelines, causes of anticoagulation under-use and its clinical outcomes, based on claims-data of 183,448 patients.
Wilke T; Groth A; Mueller S; Pfannkuche M; Verheyen F; Linder R; Maywald U; Kohlmann T; Feng YS; Breithardt G; Bauersachs R
Thromb Haemost; 2012 Jun; 107(6):1053-65. PubMed ID: 22398417
[TBL] [Abstract][Full Text] [Related]
14. Impact of oral anticoagulation in patients with atrial fibrillation at very low thromboembolic risk.
Verbrugge FH; Martin AC; Siegal D; Pieper K; Illingworth L; Camm AJ; Fox KAA
Heart; 2020 Jun; 106(11):845-851. PubMed ID: 31806700
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and management of atrial fibrillation by primary care physicians in Italy : a retrospective, observational analysis.
Piccinocchi G; Laringe M; Guillaro B; Arpino G; Piccinocchi R; Nigro G; Calabrò P
Clin Drug Investig; 2012 Nov; 32(11):771-7. PubMed ID: 23018284
[TBL] [Abstract][Full Text] [Related]
16. A retrospective cohort study of oral anticoagulant treatment in patients with acute coronary syndrome and atrial fibrillation.
Mai L; Wu Y; Luo J; Liu X; Zhu H; Zheng H; Liang G; Zhang Y; Huang Y
BMJ Open; 2019 Sep; 9(9):e031180. PubMed ID: 31530618
[TBL] [Abstract][Full Text] [Related]
17. Flaws in Anticoagulation Strategies in Patients With Atrial Fibrillation at Hospital Discharge.
Kartas A; Samaras A; Vasdeki D; Dividis G; Fotos G; Paschou E; Forozidou E; Tsoukra P; Kotsi E; Goulas I; Efthimiadis G; Karvounis H; Tzikas A; Giannakoulas G
J Cardiovasc Pharmacol Ther; 2019 May; 24(3):225-232. PubMed ID: 30599759
[TBL] [Abstract][Full Text] [Related]
18. Stroke Risk Status, Anticoagulation Treatment, and Quality-of-Life in Chinese Patients with Atrial Fibrillation: China Registry of Atrial Fibrillation (CRAF).
Sun Y; Zhu J; Ma C; Liu S; Yang Y; Hu D
Cardiovasc Ther; 2019; 2019():7372129. PubMed ID: 31772614
[No Abstract] [Full Text] [Related]
19. Assessment of Trends in Guideline-Based Oral Anticoagulant Prescription for Patients With Ischemic Stroke and Atrial Fibrillation in China.
Gu HQ; Yang X; Wang CJ; Zhao XQ; Wang YL; Liu LP; Meng X; Jiang Y; Li H; Liu C; Xiong YY; Fonarow GC; Wang D; Xian Y; Li ZX; Wang YJ
JAMA Netw Open; 2021 Jul; 4(7):e2118816. PubMed ID: 34323982
[TBL] [Abstract][Full Text] [Related]
20. Racial Disparity in the Prescription of Anticoagulants and Risk of Stroke and Bleeding in Atrial Fibrillation Patients.
Tedla YG; Schwartz SM; Silberman P; Greenland P; Passman RS
J Stroke Cerebrovasc Dis; 2020 May; 29(5):104718. PubMed ID: 32122777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
